INFAI products for various gastrointestinal,
metabolic and cardiovascular diseases
We offer you a range of products for various gastrointestinal, metabolic and cardiovascular diseases
Helicobacter Test INFAI
Helicobacter Test INFAI is a ¹³C-urea breath test for the direct, non-invasive detection of the bacterium Helicobacter pylori.
Metabo Test INFAI
Urinary metabolite screening for diagnosing metabolic diseases in newborns and children. The test is evaluated by NMR spectroscopy.
Cardio Test INFAI
Lipoprotein analysis in serum for risk assessment of cardiovascular diseases. The test is evaluated by NMR spectroscopy.
INFAI offers pharmaceutical companies clinical studies with the following products (Helicobacter Test INFAI, Gastromotal, Pancreo-Lip).
Advantages of INFAI breath tests
Simple test performance
High sensitivity and specificity
Significant cost reduction
INFAI specializes in the transfer of advanced analytical technology in the field of medical diagnostics and the development of innovative pharmaceutical products. The company is a pioneer in the use of stable isotopes compounds with IRMS and NMR spectrometer in field of gastroenterology, oncology and metabolic diseases. INFAI’s laboratories in Bochum, Germany and York in United Kingdom are equipped with state-of-the-art instruments. These facilities are used for internal research and product development, but are also available for collaborations and contract research.
Innovations from INFAI
INFAI has developed a number of different innovative products in recent years that are used to study gastrointestinal and cardiovascular diseases as well as metabolic disorders. INFAI’s laboratories are used for internal research and product development, but are also available for collaborative and contract research. Over the past 10 years, a number of non-invasive, highly efficient stable isotope breath tests (Helicobacter Test, Gastromotal, Pancreo-Lip, Lactoin) have been developed. Some of these products have already been approved by EMA.